Accuri C6 Flow Cytometer System
Originally published online as doi:10.1189/jlb.1008666 on August 20, 2009

Published online before print August 20, 2009
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.1008666v1
86/5/1049    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Bahbouhi, B.
Right arrow Articles by Soulillou, J.-P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bahbouhi, B.
Right arrow Articles by Soulillou, J.-P.
Related Collections
Right arrowRelated Article
(Journal of Leukocyte Biology. 2009;86:1049-1063.)
© 2009 Society for Leukocyte Biology

Peripheral blood CD4+ T lymphocytes from multiple sclerosis patients are characterized by higher PSGL-1 expression and transmigration capacity across a human blood-brain barrier-derived endothelial cell line

Bouchaib Bahbouhi*, Laureline Berthelot*, Ségolène Pettré*, Laure Michel*, Sandrine Wiertlewski{dagger}, Babette Weksler{ddagger}, Ignacio-Andres Romero§, Florence Miller||, Pierre-Olivier Couraud||, Sophie Brouard*, David-Axel Laplaud*,{dagger},1 and Jean-Paul Soulillou*,1,2

* INSERM, UMR 643, CHU Nantes, Institut de Transplantation et de Recherche en Transplantation, ITERT, Université de Nantes, Faculté de Médecine, and CHU Hôtel Dieu, Nantes, France;
{dagger} Service de Neurologie, Hôpital Laennec, CHU de Nantes, Nantes, France;
{ddagger} Weill Cornell Medical College, Division of Hematology-Oncology, New York, New York, USA;
§ Faculty of Science Walton Hall, Milton Keynes, United Kingdom; and
|| Institut Cochin, Université Paris Descartes, INSERM, U567, and CNRS, UMR 8104, Paris, France

2. Correspondence: INSERM, UMR 643, Institut de Transplantation et de Recherches en Transplantation, ITERT, 30 Boulevard Jean Monnet, Nantes, 44900 France. E-mail: jean-paul.soulillou{at}univ-nantes.fr

ABSTRACT

Mechanisms of T lymphocyte trafficking in the brain remain unclear in MS. We hypothesized that MS is associated with increased CD4+ and CD8+ T lymphocyte trafficking across the BBB. To test this hypothesis, we calculated the frequency of PSGL-1+/CD4+ and PSGL-1+CD8+ or LFA-1+/CD4+/CD8+ T cells in the PBMC of 27 patients with a RR-MS (21 untreated and six IFN-β-treated) and 18 HI. Next, we measured their ex vivo TR across resting and TNF-{alpha}-activated human BBB-derived hCMEC/D3 endothelial layers under static conditions. The frequency of PSGL-1+CD4+ T lymphocytes was significantly higher in treated or untreated MS patients than HI. Furthermore, resting hCMEC/D3 TR of CD4+ lymphocytes (purified or in PBMC) from treated or untreated MS patients were significantly higher than those of HI and associated with significant enrichments of CD4+PSGL+ or CD4+PSGL-1+CD45RO+ T cells in their transmigrating fractions. The TR of CD4+ and CD8+ from MS patients across TNF-{alpha}-activated hCMEC/D3 were also significantly higher than that observed in HI. Resting hCMEC/D3 transmigration was blocked significantly by anti-PSGL-1/anti-LFA-1 in all groups, and anti-VLA-4 inhibited transmigration of MS T cells specifically. Purified PSGL-1-negative CD4+ lymphocytes transmigrated resting hCMEC/D3 with <10% of transmigrating cells re-expressing PSGL-1, suggesting PSGL-1-independent transmigration mechanisms. The frequency of PSGL-1 was unchanged in CD8+ cells from MS patients, whereas CD8+LFA-1high were reduced significantly in IFN-β-treated patients specifically. Collectively, MS is associated with an expanding pool of PSGL-1+CD4+ T lymphocytes able to transmigrate the BBB endothelium in vitro and possibly contributing to brain pathology.

Key Words: LFA-1 • VLA-4 • p-selectin • VCAM-1 • ICAM-1 • inflammation • endothelium


Related Article

Editorial: PSGL-1—the hidden player in T cell trafficking into the brain in multiple sclerosis?
Britta Engelhardt
J. Leukoc. Biol. 2009 86: 1023-1025. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
B. Engelhardt
Editorial: PSGL-1--the hidden player in T cell trafficking into the brain in multiple sclerosis?
J. Leukoc. Biol., November 1, 2009; 86(5): 1023 - 1025.
[Full Text] [PDF]